Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 5.250%12/0
-
Market price (% of par)
-
161.46%
-
Total 13F principal
-
$87,500,000
-
Principal change
-
+$2,150,000
-
Total reported market value
-
$141,157,000
-
Number of holders
-
12
-
Value change
-
+$3,228,692
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q1 2016
As of 31 Mar 2016,
LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 was held by
12 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$87,500,000
in principal (par value) of the bond.
The largest 10 bondholders included
LINDEN ADVISORS LP, UBS ASSET MANAGEMENT AMERICAS INC, CITADEL ADVISORS LLC, UBS OCONNOR LLC, LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, ANGELO GORDON & CO., L.P., Polygon Management Ltd., Clearbridge Investments, LLC, and Verition Fund Management LLC.
This page lists
12
institutional bondholders reporting positions
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.